2. Signaling Pathways
  3. GPCR/G Protein
  4. Vasopressin Receptor
  5. Vasopressin Receptor Isoform

Vasopressin Receptor

 

Vasopressin Receptor Related Products (62):

Cat. No. Product Name Effect Purity
  • HY-17572A
    Atosiban acetate
    		Antagonist 99.76%
    Atosiban acetate (RW22164 acetate;RWJ22164 acetate) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research.
  • HY-17572
    Atosiban
    		Antagonist 99.55%
    Atosiban (RW22164; RWJ22164) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research.
  • HY-A0182A
    Felypressin acetate
    		Agonist 98.31%
    Felypressin acetate (PLV-2 acetate) is a non-catecholamine vasoconstrictor and a vasopressin 1 agonist. Felypressin acetate is widely used in dental procedures.
  • HY-10066
    Nelivaptan
    		Antagonist 98.35%
    Nelivaptan (SSR-149415) is a selective and orally active vasopressin V1b Receptor antagonist (Ki: 3.7 and 1.3 nM for native and recombinant rat V1b receptors, respectively). Nelivaptan inhibits arginine vasopressin (AVP)-induced Ca2+ increase and corticotropin secretion. Nelivaptan can be used for research of stress and anxiety.
  • HY-P0083
    Ornipressin
    		Agonist 99.63%
    Ornipressin is a potent vasoconstrictor, hemostatic and renal agent. Ornipressin is also a vasopressin agonist specificly targeting to V1 receptor.
  • HY-114594
    Khusimol
    		Ligand
    Khusimol is a compound used in chemotherapy for oral squamous cell carcinoma.
  • HY-A0182R
    Felypressin (Standard)
    		Agonist
    Felypressin (Standard) is the analytical standard of Felypressin. This product is intended for research and analytical applications. Felypressin (PLV-2) is a non-catecholamine vasoconstrictor and a vasopressin 1 agonist. Felypressin is widely used in dental procedures.
  • HY-172427
    Elsovaptan
    		Antagonist
    Elsovaptan is the antagonist for vasopressin receptor that can be used in researchs of Alzheimer disease.
  • HY-P1185
    Antagonist G
    		Antagonist 99.96%
    Antagonist G is a potent vasopressin antagonist. Antagonist G is also a weak antagonist of GRP and Bradykinin. Antagonist G induces AP-1 transcription and sensitizes cells to chemotherapy.
  • HY-P3066
    SKF 100398
    		99.48%
    SKF 100398 (d(CH2)5Tyr(Et)VAVP), an arginine vasopressin (AVP) analogue, is a specific antagonist of the antidiuretic effect of exogenous and endogenous AVP.
  • HY-A0182
    Felypressin
    		Agonist 99.62%
    Felypressin (PLV-2) is a non-catecholamine vasoconstrictor and a vasopressin 1 agonist. Felypressin is widely used in dental procedures.
  • HY-P0041A
    F992 TFA
    		Inhibitor 98.19%
    F992 TFA is an antidiuretic peptide and vasopressin (antidiuretic hormone) analogue.
  • HY-P1809A
    Velmupressin acetate
    		Agonist 99.47%
    Velmupressin (c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2) acetate is a potent, selective and short-acting peptidic V2 receptor (V2R) agonist with EC50s of 0.07 and 0.02 nM for hV2R and rV2R, respectively.
  • HY-109181
    Lazuvapagon
    		Agonist
    Lazuvapagon (SK-1404) is a vasopressin V2 receptor agonist for the research of nocturia.
  • HY-12554B
    Terlipressin acetate
    		Agonist 98.46%
    Terlipressin acetate is a vasopressin analogue with potent vasoactive properties. Terlipressin acetate is a highly selective vasopressin V1 receptor agonist that reduces the splanchnic blood flow and portal pressure and controls acute variceal bleeding. Terlipressin acetate exerts anti-inflammatory and anti-oxidative effects. Terlipressin acetate has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research.
  • HY-162394
    Vasopressin V2 receptor antagonist 2
    		Antagonist 99.81%
    Vasopressin V2 receptor antagonist 2 (Compound 33) is an antagonist of the arginine vasopressin V2 receptor (V2R) with a Ki value of 6.2 nM. Vasopressin V2 receptor antagonist 2 can effectively reduce cAMP levels, thereby inhibiting the growth of renal cysts[1].
  • HY-12554
    Terlipressin
    		Agonist
    Terlipressin is a vasopressin analogue with potent vasoactive properties. Terlipressin is a highly selective vasopressin V1 receptor agonist that reduces the splanchnic blood flow and portal pressure and controls acute variceal bleeding. Terlipressin exerts anti-inflammatory and anti-oxidative effects. Terlipressin has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research.
  • HY-P1574A
    [Arg8]-Vasotocin TFA
    		98.41%
    [Arg8]-Vasotocin (TFA) is a vertebrate neurohypophyseal peptide of the vasopressin/oxytocin hormone family.
  • HY-P4683A
    (Phenylac1,D-Tyr(Et)2,Lys6,Arg8,des-Gly9)-Vasopressin acetate
    		Antagonist 99.81%
    (Phenylac1,D-Tyr(Et)2,Lys6,Arg8,des-Gly9)-Vasopressin is a potent vasopressin V1 receptor (VP V1R) antagonist. (Phenylac1,D-Tyr(Et)2,Lys6,Arg8,des-Gly9)-Vasopressin significantly decreases the mean arterial pressure (MAP) in rats.
  • HY-P2538
    Big Endothelin-1 (1-38), human
    		Agonist
    Big Endothelin-1 (1-38), human is the precursor of endothelin-1. Endothelin-1 (ET-1) is a potent vasopressor peptide.